Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

EMERALD Pancreas

Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer


A Phase II Non-Randomized, Open-label, Multi-centre Study of the Safety and Efficacy of Tebentafusp in Melanoma with Molecular Relapsed Disease


Oxford Pre-Cancerous Lymphoproliferative Disorders: Analysis and Interception study


Windows trial of INsulin-like Growth factor neutralising antibody Xentuzumab in MEN scheduled for radical prostatectomy


Observational study to assess a multi-cancer early detection test in individuals referred with signs and symptoms of cancer


CEeDD: Sonosensitive particles and ultrasound to enhance drug delivery in metastatic colorectal cancer


Sample Collection for The Integration and Analysis of Data Using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases


IMP-MEL: IMM60 & pembrolizumab in Melanoma and NSCLC


ARCADIAN: Atovaquone with Radical ChemorADIotherapy in locally Advanced NSCLC


Chemoradiation with Enadenotucirev as a radiosensitiser in locally Advanced Rectal cancer


PanDox: Targeted Doxorubicin in Pancreatic tumours


Ipilimumab with Temozolomide versus Temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma


Paclitaxel, olaparib and cediranib in platinum-resistant ovarian cancer.